Treatment and Survival of Elderly Patients with Stage I–II Pancreatic Cancer: A Report of the EURECCA Pancreas Consortium

BACKGROUND: Elderly patients with pancreatic cancer are underrepresented in clinical trials, resulting in a lack of evidence. OBJECTIVE: The aim of this study was to compare treatment and overall survival (OS) of patients aged ≥ 70 years with stage I–II pancreatic cancer in the EURECCA Pancreas Cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Groen, Jesse V., Douwes, Tom A., van Eycken, Elizabeth, van der Geest, Lydia G. M., Johannesen, Tom B., Besselink, Marc G., Koerkamp, Bas Groot, Wilmink, Johanna W., Bonsing, Bert A., Portielje, Johanna E. A., van de Velde, Cornelus J. H., Bastiaannet, Esther, Mieog, J. Sven D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Pancreatic Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669775/
https://www.ncbi.nlm.nih.gov/pubmed/32388741
http://dx.doi.org/10.1245/s10434-020-08539-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669775/
https://www.ncbi.nlm.nih.gov/pubmed/32388741
http://dx.doi.org/10.1245/s10434-020-08539-x

Ejemplares similares